This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Golab, J. Articles by Jakóbisiak, M. Search for Related Content PubMed PubMed Citation Articles by Golab, J. Articles by Jakóbisiak, M.

Erythropoietin Restores the Antitumor Effectiveness of Photodynamic Therapy in Mice with Chemotherapy- induced Anemia¹

Jakub Goab², Dominika Olszewska, Pawe Mróz, Katarzyna Kozar, Rafa Kamiski, Ahmad Jalili and Marek Jakóbisiak

Department of Immunology, Center of Biostructure, The Medical University of Warsaw, 02-004 Warsaw, Poland

Purpose: The study was designed to examine the impact ofanemia on the antitumor efficacy of photodynamic therapy (PDT) in a murine colon-26 adenocarcinoma model syngeneic with BALB/c mice.

Experimental Design: Acute hemolytic anemia was induced by a single i.p. injection of phenylhydrazine hydrochloride (150 mg/kg). Anemia induced by i.p. administration of carboplatin (100 mg/kg) was corrected by s.c. treatment with recombinant human erythropoietin (1000 units/kg/day). The effectiveness of PDT (10 mg/kg Photofrin, 150 J/cm² laser dose) was evaluated by measurements of the footpad edema and tumor volume. All of the RBC-related parameters were measured from the tail vein.

Results: Phenylhydrazine hydrochloride injection resulted in a blunted response of normal tissues to Photofrin-mediated PDT-induced edema formation. Similarly, the antitumor response in mice with hemolytic anemia was nearly completely abrogated. The antitumor effectiveness of PDT was also significantly diminished in a more realistic clinical situation when anemia was induced by administration of carboplatin. Importantly, administration of recombinant human erythropoietin completely restored the sensitivity of the tumor to PDT in carboplatin-treated mice.

Conclusions: These results indicate that anemia can negatively influence the therapeutic effectiveness of PDT. For optimal antitumor response anemia should be corrected before PDT procedure.

This article has been cited by other articles:

				P. Solar, J. Koval, J. Mikes, J. Kleban, Z. Solarova, J. Lazur, I. Hodorova, P. Fedorocko, and A. J. Sytkowski Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells Mol. Cancer Ther., August 1, 2008; 7(8): 2263 - 2271. [Abstract] [Full Text] [PDF]

				L. Zhong, J. Bradley, W. Schubert, E. Ahmed, A. P. Adamis, D. T. Shima, G. S. Robinson, and Y.-S. Ng Erythropoietin Promotes Survival of Retinal Ganglion Cells in DBA/2J Glaucoma Mice Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1212 - 1218. [Abstract] [Full Text] [PDF]

				M. Pak, M. A. Lopez, V. Gabayan, T. Ganz, and S. Rivera Suppression of hepcidin during anemia requires erythropoietic activity Blood, December 1, 2006; 108(12): 3730 - 3735. [Abstract] [Full Text] [PDF]

				J. Tovari, R. Gilly, E. Raso, S. Paku, B. Bereczky, N. Varga, A. Vago, and J. Timar Recombinant Human Erythropoietin {alpha} Targets Intratumoral Blood Vessels, Improving Chemotherapy in Human Xenograft Models Cancer Res., August 15, 2005; 65(16): 7186 - 7193. [Abstract] [Full Text] [PDF]

				M. J. Weiss New Insights Into Erythropoietin and Epoetin Alfa: Mechanisms of Action, Target Tissues, and Clinical Applications Oncologist, December 1, 2003; 8(90003): 18 - 29. [Abstract] [Full Text] [PDF]

				M. Makowski, T. Grzela, J. Niderla, M. Lazarczyk, P. Mroz, M. Kopee, M. Legat, K. Strusinska, K. Koziak, D. Nowis, et al. Inhibition of Cyclooxygenase-2 Indirectly Potentiates Antitumor Effects of Photodynamic Therapy in Mice Clin. Cancer Res., November 1, 2003; 9(14): 5417 - 5422. [Abstract] [Full Text] [PDF]

				J. Golab, D. Nowis, M. Skrzycki, H. Czeczot, A. Baranczyk-Kuzma, G. M. Wilczynski, M. Makowski, P. Mroz, K. Kozar, R. Kaminski, et al. Antitumor Effects of Photodynamic Therapy Are Potentiated by 2-Methoxyestradiol. A SUPEROXIDE DISMUTASE INHIBITOR J. Biol. Chem., January 3, 2003; 278(1): 407 - 414. [Abstract] [Full Text] [PDF]